Faced with lower US profits, pharmaceutical companies could demand higher prices elsewhere in the world, or even withdraw products entirely
Get our breaking news email, free app or daily news podcast
Donald Trump’s pressure on medicine companies could drive up the cost of Australia’s Pharmaceutical Benefits Scheme (PBS) or see companies withdraw some medicines from Australian shelves , experts have warned.
The US president on Monday threatened to force medicine companies to lower their prices in the US, giving them 30 days to cut costs or face more severe action in an executive order.
Sign up for Guardian Australia’s breaking news email
About Author
More Stories
Iran-Israel ceasefire offer has been made, says Macron, as Trump exits G7 summit early
Israeli stands at Paris airshow shut down ‘by order of French government’
Pacific faces ‘critical moment’ in fight for press freedom, media watchdog warns